Who is affected by this change?

This affects Independence Blue Cross OB-GYN providers on Commercial plans.

When does this change take effect?

This change is effective Mar 5, 2025.

Back to dashboard

CommercialCoverageMedium impact

11.06.10a, Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis

Independence Blue Cross·OB-GYN·Medical Policy

Effective date

Mar 5, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

This is a reissued medical policy for laparoscopic, percutaneous, and transcervical techniques for uterine fibroid myolysis. The policy has been updated for commercial plans with an effective date of March 5, 2025.

Action Required

Action needed

Before March 5, 2025: Billing team should review the updated policy 11.06.10a for uterine fibroid myolysis procedures at the provided URL to understand any coverage or documentation changes. Update internal guidelines and inform OB-GYN providers of any new requirements for laparoscopic, percutaneous, and transcervical fibroid treatments.

Related policy hubs

Independence Blue Cross policies OB-GYN